Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Golden Meditech FY2011-12 Interim Results

      Newly Acquired Hospital in Shanghai Commenced Revenue Contribution

      Medical Insurance Administration Business Launched with Positive Feedbacks

      Adjusted Profit Attributable to Shareholders up 7%

      Adjusted Basic Earnings per Share Reached 4.28 HK Cents


      News provided by

      Golden Meditech Holdings Limited

      Nov 30, 2011, 07:09 ET

      Share this article

      Share this article


      HONG KONG, Nov. 30, 2011 /PRNewswire-Asia-FirstCall/ --



      6 months ended


      HK$ '000

      Sept 30 2011

      Sept 30 2010

      H-o-H (%)





      Revenues




      Hospital Management Service Income

      62,747,000

      38,048,000

      65%

      Medical Insurance Administration Service Income

      379,000

      -

      NA

      Medical Devices Sales

      81,900,000

      80,322,000

      2%

      Medical Accessories Sales

      49,994,000

      44,437,000

      13%

      Sales Income from Chinese Herbal Medicine Business

      15,862,000

      -

      NA


      210,882,000

      162,807,000

      30%





      Share of Profit from Associates




      China Cord Blood Corporation ("CCBC," CO:US)

      29,728,000

      21,643,000

      37%

      China National Medical Equipment Industry Corp. (CMIC)

      2,272,000

      2,264,000

      0%

      FunTalk China Holdings Ltd. (Privatized in August 2011)

      40,094,000

      38,040,000

      5%





      Profit After Tax

      84,425,000

      161,277,000

      (48%)





      Adjusted Profit Attributable to Shareholders*

      83,518,000

      77,854,000

      7%

      Profit Attributable to Shareholders

      76,645,000

      165,574,000

      (54%)





      Adjusted Earnings Per Share (Basic)#

      4.28 HK cents

      4.62 HK cents

      (7%)

      Earnings Per Share (Basic)

      3.93 HK cents

      9.83 HK cents

      (60%)





      *Excluding the non-cash and non-operating loss of HK$41,526,000 due to volatility in the global financial markets which led to decline in the value of securities and previously issued convertible notes and non-operating gain of HK$34,653,000 due to gain on disposal of partial interests in an associate

      # Based on Adjusted Profit Attributable to Shareholders



      Golden Meditech Holdings Limited ("Golden Meditech," together with its subsidiaries collectively as the "Group," - 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, is pleased to announce the Group's interim results for the six months ended 30 September 2011.  

      Reporting satisfactory growth in both Healthcare Services Segment and Medical Devices Segment, the Group's core businesses, total turnover amounted to HK$210,882,000, with 30% growth compared to the previous interim period.  Excluding the non-cash and non-operating loss of HK$41,526,000 due to volatility in global financial markets which led to the decline in value of the Group's securities and previously issued convertible notes, and non-operating gain of HK$34,653,000 due to gain on disposal of partial interest in an associate, the adjusted profit attributable to equity shareholders of the Company should amount to HK$83,518,000, representing 7% increase over the previous corresponding period.  

      Healthcare Services Segment

      Healthcare Services Segment, which consists of the Group's Hospital Management Business and GM-Medicare, the specialised medical insurance administration business, accounted for 30% of total turnover compared to 23% in the previous reporting period, reflecting the inclusion of revenue contribution from the newly acquired Shanghai East International Medical Centre ("SEIMC").  

      Several key events took place during the interim period, including the expansion of Daopei Hospital in Beijing and the acquisition of SEIMC, a joint-venture with the renowned Shanghai East Hospital serving mostly the premium healthcare services market, setting the stage for this segment to become the key growth and revenue driver for the Group going forward.  Hence revenues from the hospital management operations reached HK$62,747,000 during the interim period with 65% increase relative to the previous interim period.  

      Contribution from China Cord Blood Corporation (or "CCBC," CO.US), the Group's associate company, continued to report impressive revenue growth of 20% for the first half of the fiscal year relative to the previous year, contributing HK$29,728,000 to the Group during the interim period.  CCBC is already progressing toward establishing its third stem cell cord blood bank facility in Zhejiang Province, after Beijing and Guangdong.  In consideration of its excellent earnings potential and the low market capitalisation, the Group has increased its stake in CCBC to 41% as of this announcement date.

      We are delighted to report that GM-Medicare, our medical insurance administration business, commenced operation during the review period with positive feedback from the market, substantiating our initial strategy to serve as the missing-link between multiple stakeholders in the medical insurance market in China.  

      Medical Devices Segment

      For the relevant interim period, Medical Devices Segment, which constitutes the Group's own-branded blood-related medical devices manufacturing and distribution business and a stake in China Medical National Equipment Industry Corp. ("CMIC"), remained as the largest source of revenue, contributing HK$131,894,000 that is equivalent to 63% of the Group's total turnover.  The segment has benefited from the increase in medical devices accessories sales which accounted for 38% of the revenues for Medical Devices segment, the segment reported 6% growth.

      Strategic Investment Projects

      The Group also disposed 2% of the shares of the previously NASDAQ-listed FunTalk China Holdings Limited for US$15 million, realizing an unaudited gain of HK$34,653,000 following the privatisation in August 2011, with an implied value of the entire company at US$430 million.  The Group held 19.8% of the company as of 30 September 2011.  FunTalk China contributed HK$40,094,000 to the Group's net profit as an associate company for the interim reporting period, representing 5% increase from the previous year in spite of the decrease in our shareholding during the period.

      Outlook and Strategies

      Mr. KAM Yuen, Chairman and Chief Executive Officer of the Group, commenting on the interim results of the Group, said, "As our current strategies denotes, the management envisages the healthcare services segment will increasingly become a key business focus for the Group, taking both its brand presence and resources to the next level.  The Healthcare Services Segment such as our hospital and related services as well as medical insurance administrative business, GM-Medicare, will directly benefit from China's growing and increasingly affluent middleclass, which has been a strong driving force behind the impressive growth in the industry, demanding for better care as well as newer products and services.   As we are confident that the ongoing medical reform in China will continuously create more business opportunities that are complementary to our unique strategic position, we are equally confident in our ability to capture these emerging opportunities on an integrated business platform with distinctive synergies between each operation, offering promising returns for our shareholders in the long run."  

      About Golden Meditech Holdings Limited

      Golden Meditech Holdings Limited is China's leading integrated-healthcare enterprise.  Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities.  Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

      For inquiries, please contact the Investor Relations Department:


      Golden Meditech Holdings Limited

      Address:

      48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong

      Tel:

      +852-3605-8180

      Fax:

      +852-3605-8181

      Email:

      [email protected]




      SOURCE Golden Meditech Holdings Limited

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.